One of his skills deserves special mention. Having been a child patient himselfhe never forgot the dread that little children have of doctors. He cared for very many children -some with bone and joint tuberculosis, some the victims of trauma and some with congenital deformities. At winning their trust and cooperation he had no peer, and generations of crippled children remember him with gratitude and affection.
Leslie Turner 0141-0768/87/ 020126-02/$02.00/0 @1987 The Royal Society of Medicine
Medico-Pharmaceutical Forum
On 9 June 1986 the Medico-Pharmaceutical Forum was very pleased to move into a new office on the third floor of the recently refurbished part of the Royal Society of Medicine. It shares its office with The Association of Medical Advisers in the Pharmaceutical Industry (AMAPI). Mrs Jacqueline Wase· Bailey, who has for many years served AMAPI so well, will now look after the interests of both groups and their membership.
The Medico-Pharmaceutical Forum was set up in 1968 as a result of joint discussions with the Association of the British Pharmaceutical Industry (ABPI) and the Royal Colleges and major medical societies in England and Scotland. The Royal Society of Medicine, and in particular their recently retired Executive Director, Mr RT Hewitt, played a major part in creating the Forum and it is therefore most appropriate that we should now be functioning out of that learned Society. The aims of the Medico-Pharmaceutical Forum are:
(1) To consider matters of joint interest to the medical profession and the pharmaceutical industry.
(2) To undertake, sponsor or promote studies of problems of mutual interest. (3) To make recommendations where appropriate.
To this end it formed a Statutory Body composed of representatives of the Colleges and Societies (currently 13) and 13 representatives appointed by ABPI. This Statutory Body meets twice a year in June and December to decide on Forum policy and has as its officers a Chairman, a Vice-Chairman, an Immediate Past Chairman, an Honorary Secretary and an Honorary Treasurer. These posts are shared between the academic representation and those representing the pharmaceutical industry. In addition an Executive Committee is appointed which meets four times a year in January, April, July and October to organize the programme of activities. This Committee comprises the officers and four ordinary members from academia and four from the ABPI.
The main activities ofthe Forum since its inception have been: (a) to form working parties to produce reports on subjects of mutual concern to the medical profession and the industry; (b) to organize symposia or workshops on relevant subjects; (c) to publish booklets on appropriate topics. A full list of publications is available from the Forum officeor from the ABPI, but in recent years events of note have been meetings on such subjects as: Medicine and the media; Education of medical students in relation to drug development, safety and efficacy; Biomedical research involving human subjects; Informing patients about medicines. There have been working parties on: Clinical trials; Medicine and the media; and Medical student education. Many of these have resulted in publications or reports.
Weare looking forward to an interesting programme during the next two years under the Chair-
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Admission to medical school: from audit to action Sir, I read with interest the editorial on this subject by Horton (September 1986 JRSM, p 504), though was a little disturbed to read that 'it is naturally desirable that factors such as medical parents, social class, private education, race and sex do not become significant predictors of shortlisting or interview success'. I wonder what evidence Mr Horton has when he suggests that the potential student who has been brought up in a medical family and thereby knows a number of the problems, who comes from social class A or B, whose parents have sacrificed a considerable portion of their income to ensure that he has a good education, and who is British and male, has not all the qualifications for becoming a first-class doctor, be he general practitioner or hospital consultant.
RoGER GRACE Consultant Surgeon The Royal Hospital, Wolverhampton

*Dr Horton replies below:
Sir, I am not aware of any evidence from the literature to refute or support the contention that those who possess the qualities stated by Mr Grace would not become excellent doctors. However, this was not the point being made. I was attempting to discuss the proposal that, at a time of increasing competition for potentially fewer places at medical school, admissions procedures ought to be audited in order to ensure total impartiality in selection. There certainly is evidence that this is not the case.
Collier and Burkel analysed the sex and race of final year students at London medical schools between 1982 and 1984 and found significant differences in the proportions of women and non-whites between the different schools. These differences remained consistent from year to year, suggesting it was not merely due to chance alone. They concluded that significant racial and sexual discrimination was operating within those schools studied.
It is the rather alarming evidence of this sort which provides the impetus for monitoring student admissions to medical school. RICHARD BH 4 is a cofactor in the biosynthesis of the monoamine neurotransmitters, dopamine, noradrenaline, and serotonin". BH 4 is biosynthesized from guanosine triphosphate via dihydroneopterin triphosphate". Complete BH 4 synthesis deficiency leads to gross neurological disease whilst partial deficit can lead to neurological and mental impairment.'. Consequently BH 41eveis have been investigated in several neurological disease states including Alzheimer's disease (AD).
Dihydroneopterin triphosphate and BH 4 give rise to a mixture of tetrahydro-, dihydroand fully oxidized derivatives in body tissues and fluids. These can be conveniently measured by high-performance liquid chromatography, after acid/iodine oxidation to convert all the derivatives into the fully oxidized fluorescent forms neopterin (N) and biopterin (B)4, Reduced BH 4 synthesis can be shown by significantly lowered levels of B. A deficit in the conversion
